Zhuhai Sailong Pharmaceutical Co Ltd (002898) — Capital Reinvestment Ratio
Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a Capital Reinvestment Ratio of 0.87x as of June 2025, meaning it reinvests 1% of its operating cash flow (CN¥4.75 Million) in capital expenditures (CN¥4.15 Million). Check 002898 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhuhai Sailong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Zhuhai Sailong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Zhuhai Sailong Pharmaceutical Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025. See how much free cash does Zhuhai Sailong Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.23x | CN¥19.06 Million | CN¥23.35 Million | ▲ +43.1% |
| 2023 | 0.86x | CN¥35.71 Million | CN¥30.58 Million | ▼ -49.5% |
| 2022 | 1.70x | CN¥14.12 Million | CN¥23.94 Million | ▲ +91.0% |
| 2021 | 0.89x | CN¥35.46 Million | CN¥31.47 Million | ▼ -99.8% |
| 2020 | 366.69x | CN¥174.69K | CN¥64.06 Million | ▲ +805.2% |
| 2018 | 40.51x | CN¥3.33 Million | CN¥134.84 Million | ▲ +3554.0% |
| 2017 | 1.11x | CN¥85.13 Million | CN¥94.38 Million | ▲ +69.5% |
| 2016 | 0.65x | CN¥78.65 Million | CN¥51.43 Million | ▼ -34.3% |
| 2015 | 1.00x | CN¥47.44 Million | CN¥47.24 Million | ▲ +43.1% |
| 2014 | 0.70x | CN¥51.36 Million | CN¥35.74 Million | ▲ +712.9% |
| 2013 | 0.09x | CN¥64.84 Million | CN¥5.55 Million | — |